Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD

Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
ERJ Open Research 2020 6: 00187-2019; DOI: 10.1183/23120541.00187-2019
Nicola A. Hanania
1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hanania@bcm.edu
Alberto Papi
2Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Papi
Antonio Anzueto
3Pulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando J. Martinez
4Joan and Sanford I. Weill Dept of Medicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly A. Rossman
5AstraZeneca, Morristown, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christy S. Cappelletti
6AstraZeneca, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Duncan
6AstraZeneca, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack S. Nyberg
7Former employee of AstraZeneca, Morristown, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M. Dorinsky
6AstraZeneca, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 6 no. 2
DOI 
https://doi.org/10.1183/23120541.00187-2019

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received July 26, 2019
  • Accepted January 19, 2020
  • Published online April 27, 2020.

Copyright & Usage 
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Licence 4.0.

Author Information

  1. Nicola A. Hanania1⇑,
  2. Alberto Papi2,
  3. Antonio Anzueto3,
  4. Fernando J. Martinez4,
  5. Kimberly A. Rossman5,
  6. Christy S. Cappelletti6,
  7. Elizabeth A. Duncan6,
  8. Jack S. Nyberg7 and
  9. Paul M. Dorinsky6
  1. 1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA
  2. 2Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
  3. 3Pulmonary Medicine and Critical Care, University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, TX, USA
  4. 4Joan and Sanford I. Weill Dept of Medicine, Weill Cornell Medicine, New York, NY, USA
  5. 5AstraZeneca, Morristown, NJ, USA
  6. 6AstraZeneca, Durham, NC, USA
  7. 7Former employee of AstraZeneca, Morristown, NJ, USA
  1. Nicola Hanania, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX 77030, USA. E-mail: hanania{at}bcm.edu
View Full Text

Funding

  • AstraZeneca

Article usage

Article usage: April 2020 to August 2023

AbstractFullPdf
Apr 2020529944
May 20209450187
Jun 20202016732
Jul 2020712942
Aug 20201012031
Sep 2020425321
Oct 202039921
Nov 2020118013
Dec 202078321
Jan 202186228
Feb 202169714
Mar 202147318
Apr 20214519
May 202145613
Jun 202146622
Jul 202174213
Aug 202164918
Sep 2021168027
Oct 202135434
Nov 202128936
Dec 2021272823
Jan 20222609
Feb 2022145311
Mar 202232921
Apr 202253012
May 2022124613
Jun 202254013
Jul 202232511
Aug 202244627
Sep 202262824
Oct 202233224
Nov 202222917
Dec 202201312
Jan 20235267
Feb 202372910
Mar 20231202
Apr 20232168
May 20239166
Jun 20232168
Jul 20233198
Aug 20230186

Altmetrics

PreviousNext
Back to top
Vol 6 Issue 2 Table of Contents
ERJ Open Research: 6 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
ERJ Open Research Apr 2020, 6 (2) 00187-2019; DOI: 10.1183/23120541.00187-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
ERJ Open Research Apr 2020, 6 (2) 00187-2019; DOI: 10.1183/23120541.00187-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Material and methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

COPD

  • Early disease phenotypes in COPD
  • CBT combined with BPA during PR in patients with COPD
  • OCS to treat outpatients with AECOPD in primary care
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society